» Articles » PMID: 38001440

Plant-derived Nanovesicles: Harnessing Nature's Power for Tissue Protection and Repair

Overview
Publisher Biomed Central
Specialty Biotechnology
Date 2023 Nov 24
PMID 38001440
Authors
Affiliations
Soon will be listed here.
Abstract

Tissue damage and aging lead to dysfunction, disfigurement, and trauma, posing significant global challenges. Creating a regenerative microenvironment to resist external stimuli and induce stem cell differentiation is essential. Plant-derived nanovesicles (PDNVs) are naturally bioactive lipid bilayer nanovesicles that contain proteins, lipids, ribonucleic acid, and metabolites. They have shown potential in promoting cell growth, migration, and differentiation into various types of tissues. With immunomodulatory, microbiota regulatory, antioxidant, and anti-aging bioactivities, PDNVs are valuable in resisting external stimuli and facilitating tissue repair. The unique structure of PDNVs provides an optimal platform for drug encapsulation, and surface modifications enhance their stability and specificity. Moreover, by employing synergistic administration strategies, PDNVs can maximize their therapeutic potential. This review summarized the progress and prospects of PDNVs as regenerative tools, provided insights into their selection for repair activities based on existing studies, considered the key challenge for clinical application, and anticipated their continued prominent role in the field of biomedicine.

Citing Articles

Targeting cGAS-STING pathway for reprogramming tumor-associated macrophages to enhance anti-tumor immunotherapy.

Zhang W, Huang X Biomark Res. 2025; 13(1):43.

PMID: 40075527 PMC: 11905658. DOI: 10.1186/s40364-025-00750-w.


Leveraging plant-derived nanovesicles for advanced nucleic acid-based gene therapy.

Chai M, Gao B, Wang S, Zhang L, Pei X, Yue B Theranostics. 2025; 15(1):324-339.

PMID: 39744221 PMC: 11667239. DOI: 10.7150/thno.104507.


From Bench to Bedside: The Role of Extracellular Vesicles in Cartilage Injury Treatment.

Jin P, Liu H, Chen X, Liu W, Jiang T Biomater Res. 2024; 28:0110.

PMID: 39583872 PMC: 11582190. DOI: 10.34133/bmr.0110.


Evaluating stability and bioactivity of Rehmannia-derived nanovesicles during storage.

Chen X, He L, Chen Y, Zheng G, Su Y, Chen Y Sci Rep. 2024; 14(1):19966.

PMID: 39198513 PMC: 11358329. DOI: 10.1038/s41598-024-70334-5.


Comparison of nanovesicles derived from at different size: physical properties, composition, and bioactivity.

Chen X, Huang L, Zhang M, Lin S, Xie J, Li H Front Pharmacol. 2024; 15:1423115.

PMID: 39104384 PMC: 11298367. DOI: 10.3389/fphar.2024.1423115.


References
1.
L L, X W, Z Y . Ischemia-reperfusion Injury in the Brain: Mechanisms and Potential Therapeutic Strategies. Biochem Pharmacol (Los Angel). 2018; 5(4). PMC: 5991620. DOI: 10.4172/2167-0501.1000213. View

2.
Liu C, Yan X, Zhang Y, Yang M, Ma Y, Zhang Y . Oral administration of turmeric-derived exosome-like nanovesicles with anti-inflammatory and pro-resolving bioactions for murine colitis therapy. J Nanobiotechnology. 2022; 20(1):206. PMC: 9052603. DOI: 10.1186/s12951-022-01421-w. View

3.
Sundaram K, Mu J, Kumar A, Behera J, Lei C, Sriwastva M . Garlic exosome-like nanoparticles reverse high-fat diet induced obesity via the gut/brain axis. Theranostics. 2022; 12(3):1220-1246. PMC: 8771565. DOI: 10.7150/thno.65427. View

4.
Fang Z, Liu K . Plant-derived extracellular vesicles as oral drug delivery carriers. J Control Release. 2022; 350:389-400. DOI: 10.1016/j.jconrel.2022.08.046. View

5.
Cai J, Pan J . Beta vulgaris-derived exosome-like nanovesicles alleviate chronic doxorubicin-induced cardiotoxicity by inhibiting ferroptosis. J Biochem Mol Toxicol. 2023; 38(1):e23540. DOI: 10.1002/jbt.23540. View